Cedars-Sinai Cancer experts are available to discuss breaking news from the American Association for Cancer Research annual meeting April 25-30.
Newswise — LOS ANGELES (April 21, 2025) -- Physician-scientists from will present research at the annual meeting April 25-30 in Chicago. Topics include:
- Cancer mechanisms and therapies
- Community-embedded interventions to address HPV disease awareness
- Chronic alcohol consumption and pancreatic cancer liver metastasis
- Equity in breast cancer prognosis
- Cancer-related fatigue and racial diversity in colorectal cancer patients
- Patient response to non-small cell lung cancer therapies
- Targeted radiotherapy for triple-negative breast cancer
- Genetic differences in African American prostate cancer
- Multiplex imaging and the extracellular matrix in cancer
- Antitumor response to immunotherapy in large B-cell lymphoma
Cedars-Sinai Experts
, professor of Medicine and Biomedical Sciences, studies cancer formation, progression and metastasis using organoids and other leading-edge technologies. At the conference, he will co-chair a minisymposium, “Cancer Models: Mechanisms and Therapies.”
, professor of Medicine and Biomedical Sciences and co-director of the Cancer Prevention and Control Program at Cedars-Sinai Cancer, is an expert on the links between diet, metabolism, genetics and cancer. He will give an invited talk on “Community-Embedded Interventions to Address Human Papillomavirus Disease Awareness.”
, professor of Biomedical Sciences, is a cancer biologist who studies the genomic and epigenomic drivers of hormone-dependent cancers. At the conference, he will present research on epigenetic approaches to triple-negative breast cancer treatment, and how African ancestry shapes prostate cancer risk. He will also receive the Cancer Research Communications Award for Outstanding Journal Article.
, assistant professor of Computational Biomedicine, uses statistical and machine-learning methods to help improve the prevention and treatment of cancer and other diseases. Peng can discuss her work in developing PREDICT Breast v4, a breast cancer prognostic model that seeks to improve predictive accuracy across diverse populations and reduce disparities in prognostic outcomes.
, professor of Medicine and co-leader of the Cancer Prevention and Control Program at Cedars-Sinai Cancer, focuses on the biological, environmental, and behavioral/lifestyle aspects of cancer control, survivorship and disparities, primarily in colorectal cancer. She can discuss genetic variants associated with cancer-related fatigue in colorectal cancer patients.
, associate professor of Medicine and co-director of the Lymphoma Program at Cedars-Sinai Cancer, studies how cancer and the immune system interact. He can discuss new research on aspects of the tumor microenvironment that could predict patient outcomes, and the possibility of reversing T-cell metabolic exhaustion in large B-cell lymphoma.
, professor of Medicine and director of the Division of Medical Oncology at Cedars-Sinai Cancer, performs translational research in thoracic oncology with a focus on the development of novel therapies and biomarkers for lung cancer. She can discuss research being presented at the conference on predicting response to tyrosine kinase inhibitors in non-small cell lung cancer.
Contact
To arrange interviews with Cedars-Sinai experts, contact Christina Elston at [email protected] or 626-298-0702.
RSS